The new frontier: the bioanalysis of cell and gene therapies

Cell and gene therapies are comprised of multiple elements including living cells or viral vectors and therefore pose additional bioanalytical challenges compared with chemical or biological drugs. The capability of bioanalytical methods to monitor cell and gene therapy safety and efficacy plays a significant role in the therapy’s success. In this six-part series, we are joined by industry experts exploring topics from regulatory implications to immunogenicity testing, delving into every corner of the cell and gene therapy landscape in bioanalysis.